Peter Højholt Holland-Fischer

Medicine and Dentistry

1. Child 100%
2. Lifestyle Intervention 100%
3. Liver Disease 60%
4. Obesity 60%
5. Cohort Analysis 50%
6. Nonalcoholic Fatty Liver 50%
7. Thromboembolism 50%
8. Bleeding 50%
9. Marker 50%
10. Atrial Fibrillation 50%
11. Insulin Resistance 50%
12. Macrophage Activation 50%
13. Synapsin II 50%
14. Protein Binding 50%
15. Comorbidity 50%
16. Inpatient 50%
17. Cohort Study 50%
18. Non-Alcoholic Fatty Liver Disease 50%
19. Antithrombotic 38%
20. Alanine Aminotransferase 30%
21. Liver 26%
22. Weight Loss 25%
23. Patient 22%
24. Follow up 22%
25. CHA2DS2-VASc Score 22%
26. C Reactive Protein 20%
27. Cholesterol 20%
28. Macrophage 20%
29. Heart 18%
30. Incidence 17%
31. Woman 16%
32. Homeostatic Model Assessment 13%
33. Transplantation 12%
34. Population Research 12%
35. Long Term Survival 12%
36. Short Term Survival 12%
37. Population 12%
38. Therapeutic Procedure 12%
39. Blood 12%
40. Anticoagulation 11%
41. High Density Lipoprotein Cholesterol 10%
42. Fibrosis 10%
43. Disease Severity 10%
44. Liver Fibrosis 10%
45. Echography 10%
46. Hepatitis 10%
47. Combination Therapy 10%
48. Liver Injury 10%
49. Association 10%
50. Pediatrics 10%